DE3536669A1 - Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten - Google Patents

Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten

Info

Publication number
DE3536669A1
DE3536669A1 DE19853536669 DE3536669A DE3536669A1 DE 3536669 A1 DE3536669 A1 DE 3536669A1 DE 19853536669 DE19853536669 DE 19853536669 DE 3536669 A DE3536669 A DE 3536669A DE 3536669 A1 DE3536669 A1 DE 3536669A1
Authority
DE
Germany
Prior art keywords
ester
pca
carbon atoms
composition according
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19853536669
Other languages
German (de)
English (en)
Inventor
Yoko Abe
Yoshiaki Ibaraki Osaka Itoh
Susumu Satoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Original Assignee
Nitto Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Electric Industrial Co Ltd filed Critical Nitto Electric Industrial Co Ltd
Publication of DE3536669A1 publication Critical patent/DE3536669A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
DE19853536669 1984-10-26 1985-10-15 Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten Withdrawn DE3536669A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59226279A JPS61103840A (ja) 1984-10-26 1984-10-26 外皮投与用組成物

Publications (1)

Publication Number Publication Date
DE3536669A1 true DE3536669A1 (de) 1986-04-30

Family

ID=16842717

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853536669 Withdrawn DE3536669A1 (de) 1984-10-26 1985-10-15 Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten

Country Status (3)

Country Link
US (1) US4863952A (enExample)
JP (1) JPS61103840A (enExample)
DE (1) DE3536669A1 (enExample)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173990A3 (en) * 1984-09-03 1987-05-13 Teijin Limited External pharmaceutical composition
EP0227531A3 (en) * 1985-11-29 1987-09-16 Merck & Co. Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
EP0247507A3 (en) * 1986-05-27 1988-02-10 Hoechst Aktiengesellschaft Composition for transdermal therapeutical systems of high-ceiling diuretics, and process for producing it
EP0260452A1 (en) * 1986-08-18 1988-03-23 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparation for the transdermal administration of Nicorandil
EP0309624A1 (en) * 1986-03-27 1989-04-05 Nitto Denko Corporation Composition for enhancing percutaneous administration of medicine
EP0342056A3 (en) * 1988-05-13 1990-04-18 Unilever Plc Cosmetic composition
EP0374218A4 (en) * 1988-04-08 1991-09-11 Whitby Research Incorporated Novel transdermal penetration enhancers
US5059628A (en) * 1987-09-28 1991-10-22 Nitto Electric Industrial Co., Ltd. Medical composition for percutaneous administration
WO2007109152A3 (en) * 2006-03-17 2008-01-24 Croda Inc Amine/amide-functionalized lipophiles
EP1974715A1 (de) * 2007-03-31 2008-10-01 Zschimmer & Schwarz GmbH & Co KG Chemische Fabriken Tränklösung für Feuchttücher
EP2335480A1 (en) * 2009-12-15 2011-06-22 Cognis IP Management GmbH Biocide compositions comprising derivatives of pyroglutamic acid

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62187415A (ja) * 1986-02-12 1987-08-15 Lion Corp 経皮吸収促進用組成物
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
JP3686434B2 (ja) * 1993-10-01 2005-08-24 千寿製薬株式会社 コンタクトレンズ用剤の安定化方法
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
CN100525767C (zh) 2002-06-10 2009-08-12 欧洲凯尔特公司 防止所含活性剂被误用的经皮给药器的处置系统
US20040126323A1 (en) * 2002-08-20 2004-07-01 Ihor Shevchuk Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent
US20080020028A1 (en) * 2003-08-20 2008-01-24 Euro-Celtique S.A. Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
US20090156565A1 (en) * 2004-12-03 2009-06-18 The Children's Hospital Of Philadelphia Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
FR2908982A1 (fr) * 2006-11-23 2008-05-30 Oreal Composition cosmetique comprenant au moins un solvant volatil hydrocarbone aprotique

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2102172A1 (de) * 1971-01-18 1972-07-27 Dr. Karl Thomae Gmbh, 7950 Biberach Neue Mitel zur Behandlung und Pflege der Haut
DE2102173A1 (en) * 1971-01-18 1972-08-17 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrrolidone carboxylic acid alkyl esters prepn - having therapeutic and cosmetic activity esp for the skin
US3920814A (en) * 1972-08-18 1975-11-18 Dominique Bocher Antibiotic composition containing an antibiotic and as a potentiating agent pyrrolidone carboxylic acid or derivative thereof
DE2456634A1 (de) * 1974-11-29 1976-08-12 Thomae Gmbh Dr K 5-pyrrolidon-(2)-carbonsaeure-phenylalkanolester und deren herstellung,
DE2707814A1 (de) * 1976-02-26 1977-09-01 Unilever Nv Mittel zur pflege und behandlung der haut und verfahren zur herstellung der mittel
EP0123948A1 (en) * 1983-04-04 1984-11-07 Teijin Limited External pharmaceutical composition
EP0173990A2 (en) * 1984-09-03 1986-03-12 Teijin Limited External pharmaceutical composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
GB1563199A (en) * 1975-09-10 1980-03-19 Ici Ltd 1,2,4 triazole compounds and their use as pesticides
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2102172A1 (de) * 1971-01-18 1972-07-27 Dr. Karl Thomae Gmbh, 7950 Biberach Neue Mitel zur Behandlung und Pflege der Haut
DE2102173A1 (en) * 1971-01-18 1972-08-17 Dr. Karl Thomae Gmbh, 7950 Biberach Pyrrolidone carboxylic acid alkyl esters prepn - having therapeutic and cosmetic activity esp for the skin
US3920814A (en) * 1972-08-18 1975-11-18 Dominique Bocher Antibiotic composition containing an antibiotic and as a potentiating agent pyrrolidone carboxylic acid or derivative thereof
DE2456634A1 (de) * 1974-11-29 1976-08-12 Thomae Gmbh Dr K 5-pyrrolidon-(2)-carbonsaeure-phenylalkanolester und deren herstellung,
DE2707814A1 (de) * 1976-02-26 1977-09-01 Unilever Nv Mittel zur pflege und behandlung der haut und verfahren zur herstellung der mittel
EP0123948A1 (en) * 1983-04-04 1984-11-07 Teijin Limited External pharmaceutical composition
EP0173990A2 (en) * 1984-09-03 1986-03-12 Teijin Limited External pharmaceutical composition

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173990A3 (en) * 1984-09-03 1987-05-13 Teijin Limited External pharmaceutical composition
EP0227531A3 (en) * 1985-11-29 1987-09-16 Merck & Co. Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
EP0309624A1 (en) * 1986-03-27 1989-04-05 Nitto Denko Corporation Composition for enhancing percutaneous administration of medicine
EP0247507A3 (en) * 1986-05-27 1988-02-10 Hoechst Aktiengesellschaft Composition for transdermal therapeutical systems of high-ceiling diuretics, and process for producing it
EP0260452A1 (en) * 1986-08-18 1988-03-23 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical preparation for the transdermal administration of Nicorandil
BE1000477A3 (fr) * 1986-08-18 1988-12-20 Chugai Pharmaceutical Co Ltd Compositions pharmaceutiques pour l'administration par absorption percutanee et procede pour les preparer.
US5211943A (en) * 1986-08-18 1993-05-18 Chugai Seiyaku Kabushili Kaisha Pharmaceutical preparation for administration by percutaneous absorption and a method for their manufacture
US5059628A (en) * 1987-09-28 1991-10-22 Nitto Electric Industrial Co., Ltd. Medical composition for percutaneous administration
EP0374218A4 (en) * 1988-04-08 1991-09-11 Whitby Research Incorporated Novel transdermal penetration enhancers
EP0342056A3 (en) * 1988-05-13 1990-04-18 Unilever Plc Cosmetic composition
WO2007109152A3 (en) * 2006-03-17 2008-01-24 Croda Inc Amine/amide-functionalized lipophiles
US7781391B2 (en) 2006-03-17 2010-08-24 Croda, Inc. Amine/amide-functionalized lipophiles
EP1974715A1 (de) * 2007-03-31 2008-10-01 Zschimmer & Schwarz GmbH & Co KG Chemische Fabriken Tränklösung für Feuchttücher
EP2335480A1 (en) * 2009-12-15 2011-06-22 Cognis IP Management GmbH Biocide compositions comprising derivatives of pyroglutamic acid
WO2011072811A3 (en) * 2009-12-15 2012-03-29 Cognis Ip Management Gmbh Biocide compositions comprising derivatives of pyroglutamic acid
US8927460B2 (en) 2009-12-15 2015-01-06 Cognis Ip Management Gmbh Biocide compositions comprising derivatives of pyroglutamic acid

Also Published As

Publication number Publication date
JPS61103840A (ja) 1986-05-22
US4863952A (en) 1989-09-05
JPH0570610B2 (enExample) 1993-10-05

Similar Documents

Publication Publication Date Title
DE3536669A1 (de) Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten
DE69223624T2 (de) Taxan-derivate enthaltende arzneimittel
DE3787377T2 (de) Eindringungserhöhende mittel zur transdermalen verabreichung systemischer mittel.
DE3751761T2 (de) Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln
DE3783683T2 (de) Hautpenetration verbessernde zusammensetzungen.
DE3205504C2 (de) Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
US4847260A (en) Composition for percutaneous administration
DE2707878C2 (de) Verwendung von Mono- und/oder Diglyceriden mittelkettiger Fettsäuren
DE69908375T9 (de) Nimesulide-haltige topische arzneimittel
DD294254A5 (de) Verfahren zur herstellung von salzen des azelastins
CH643456A5 (de) Pharmazeutische zubereitung.
DE2751301A1 (de) Glucofuranose-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69803751T2 (de) Omega-aminosäure-derivate, verfahren zu deren herstellung und deren verwendung
EP0130524A2 (de) Depot-Antiphlogistika
DE2948733A1 (de) Steroidspirothiazolidinderivate, verfahren zur herstellung derselben und diese enhaltende arzneimittel
DE2504045B2 (de) 16,17 dihydro-apovincaminsaeure-2- hydroxypropylester, deren salze, verfahren zu ihrer herstellung und arzneimittel
DE4229050A1 (de) Neue 9-Chlor-Prostaglandin-Ester und -amide
DE3779833T2 (de) Zusammensetzungen enthaltend 1-substituierte azacycloalkane und deren verwendung.
DE69606364T2 (de) Prostaglandinderivate
EP0656889A1 (de) 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln
DE3709552A1 (de) Pharmazeutische zusammensetzungen
CH617927A5 (enExample)
DE69500041T2 (de) Eine Urethangruppe enthaltende, fluorierte Alkylester, ihre Herstellung, ihre Verwendung als Verdickungsmittel in nicht wässrigen Medien, und diese enthaltende Medien und Zusammensetzungen
EP0086320A1 (de) Panthenolderivate
DE2323744C3 (de) 4,4'-Bismethylen-(3-methoxy-2-naphthoesäure-triamcinolon-acetonidester) und Verfahren zu dessen Herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: A61K 47/18

8130 Withdrawal